TMates Tirzepatide Review: Full Plan Bills & Refunds
Researched & written by Alan PierceClinical Pharmacology WriterUpdated
On this page
Named injectable plan totals are public; longer-plan equivalents and refund stages need separate comparison.
Standout details
- Selected injectable menu publishes one-, three-, six- and twelve-month totals
- Medication, telemedicine visits, coaching and shipping are described as included
Things to consider
- Rounded monthly equivalents do not establish monthly installments
- Prescription written and transmitted after qualification is nonrefundable
TMates’ named injectable tirzepatide menu lists $297 for one month, $800 for three months, $1,299 for six months and $1,999 for twelve months. The longer cards display rounded monthly equivalents of $267, $217 and $167. Compare the full purchase, not just the smallest monthly label; a displayed equivalent does not establish monthly installments.3
Match format, full payment and supplied period
The product presents injectable and oral format choices, same-price-all-doses wording, medication, support and free shipping. Obtain the selected format’s actual total, prescribed preparation, supplied quantity and shipment schedule. Neither a menu strength nor a displayed format is an instruction to select or change treatment. A shared price does not establish clinical equivalence between oral and injectable preparations.3
The listed equivalents are rounded: three times $267 is not the displayed $800 total. Use the selected full amount rather than reconstructing an invoice from a rounded label. Ask what is due now, whether financing creates separate payments, what renews and which later price is authorized.3,4
The PeterMD review explains why a monthly-looking amount with a quarterly-billing qualifier does not establish a separately payable monthly plan. Compare the selected full charge rather than reconstructing it from the headline.
The product FAQ describes telemedicine visits, coaching and medication as included, without hidden fees. Coaching is not proof of credentialed dietitian support. A general inclusion statement still needs the actual selected plan and any services outside it.3
TMates: injectable plan totals
| Published detail | Decision before payment |
|---|---|
| One month: $297 | Confirm the chosen format and supply. |
| Three months: $800 total | $267/month is the displayed equivalent. |
| Six months: $1,299 total | $217/month is the displayed equivalent. |
| Twelve months: $1,999 total | $167/month is the displayed equivalent. |
Clinical review changes the refund outcome
The Terms promise a 100% refund before medical-history review. They also promise a full refund after review when the patient does not qualify for any medication-assisted weight-loss plan. That condition should not be expanded into an unconditional refund whenever a person does not receive their preferred medication.4
When review finds the patient qualifies and a prescription is written and transmitted to a pharmacy, the Terms say no refund. That cutoff can occur before shipment. Ask for the order’s clinical and pharmacy-transmission status before relying on the product’s “cancel anytime” label.3,4
If a refund request is denied, the Terms say payment plans remain in place. Stopping future participation or canceling a payment method does not itself erase the accepted purchase balance. Obtain the cancellation channel, notice deadline, renewal date and remaining obligation in writing; these pages do not establish one complete unused-prepaid-balance refund schedule.4
TMates: what changes a refund
| Published detail | Decision before payment |
|---|---|
| Before medical-history review | Terms promise a full refund. |
| After review: no qualifying weight-loss plan | Terms promise a full refund for that condition. |
| Qualifies; prescription written and transmitted | Terms state no refund. |
| Refund request denied | Payment-plan obligations remain in place. |
Identify the clinician and dispensing pharmacy
TMates Inc.’s Terms describe independent treating professionals and state that TMates does not practice medicine. The Doctors page makes broad U.S.-based and board-certification claims but does not establish a specific assigned clinician or current credential verification. The site also expressly says TMates is not itself a 503A or 503B compounding facility.4,5,6
The reviewed pages describe registered U.S. pharmacies without identifying the preparing facility for a selected prescription. Ask for the pharmacy’s name and contact details, actual treating practice, physical-location eligibility, formulation and label instructions. Generic pharmacy language is not evidence of a named network, assigned facility or a particular regulatory classification.4,6
Clinical evidence and individual care
Compounded tirzepatide is not an FDA-approved finished drug.7 SURMOUNT-1 and SURMOUNT-5 studied specific products and treatment protocols; they do not establish this service’s outcomes or equivalence of a compounded preparation.1,2 Confirm the actual prescription, risks, alternatives and label instructions with the treating clinician.
Further reading
whether compounded tirzepatide is still legal in 2026 · Zepbound side effects · the gallbladder risk · thyroid cancer warning · tirzepatide evidence guide · bmiMD · ShedRx · PeterMD · Yucca Health · best tirzepatide providers
Frequently asked questions
Is TMates tirzepatide $167 paid each month?
The twelve-month card displays a $1,999 total and a rounded $167 monthly equivalent. That does not establish monthly installments. Confirm the actual amount collected and any financing agreement.
Does TMates refund patients who are not approved?
The Terms describe a full refund before medical-history review, or after review when the patient qualifies for none of the medication-assisted weight-loss plans. That is narrower than not receiving a preferred prescription.
Is a pharmacy-transmitted prescription refundable?
The Terms say no refund when the patient qualifies, a prescription is written and it is transmitted to a pharmacy. A denied refund request does not cancel a payment plan.
References(7)
- Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
- Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
- TMates (2026). Tirzepatide: formats, plan totals and inclusions. TMates.
- TMates (2025). Terms of Service: clinical independence, payments and staged refunds. TMates.
- TMates (2026). Our Doctors: public team descriptions. TMates.
- TMates (2026). Homepage: services and compounded-medication disclosure. TMates.
- U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. U.S. Food and Drug Administration. Read source
About the author
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
Continue reading
Browse provider reviewsPeterMD Tirzepatide Review: Intro, Quarterly Billing & Refunds
PeterMD’s introductory tirzepatide label differs from its quarterly-billed rate. Compare the actual collected amount, renewal cutoff and replacement policy.
ReadbmiMD Tirzepatide Review: Plan Prices and Refund Terms
bmiMD review: $249 monthly tirzepatide, lower prepaid equivalents, conflicting cancellation deadlines and the financial limits of longer plans.
ReadIs Compounded Tirzepatide Still Legal in 2026?
Tirzepatide's shortage ended in 2024 and FDA's compounding grace period closed in early 2025. Here's the precise legal status of compounded tirzepatide in 2026.
ReadZepbound Side Effects: Full Breakdown by Frequency
Compare common Zepbound side effects by dose, see trial frequencies and learn which warning signs need prompt medical attention.
ReadTirzepatide and Gallbladder Problems
How often tirzepatide causes gallstones and cholecystitis, why rapid weight loss is part of it, and the red-flag symptoms that need urgent care.
ReadTirzepatide Thyroid Cancer Warning Explained
What tirzepatide's boxed thyroid C-cell tumor warning actually means: verbatim FDA label text, the rat data behind it, and what human evidence shows.
Read